Literature DB >> 26944840

Thermal Inactivation of Mycobacterium avium subsp. paratuberculosis in Artificially Contaminated Milk by Direct Steam Injection.

Mats Peterz1, Sophie Butot2, Balamurugan Jagadeesan2, Douwe Bakker3, John Donaghy4.   

Abstract

UNLABELLED: The efficiency of direct steam injection (DSI) at 105 °C for 3 s to inactivate Mycobacterium avium subsp. paratuberculosis in milk at a pilot-plant scale was investigated. Milk samples were artificially contaminated with M. avium subsp. paratuberculosis and also with cow fecal material naturally infected with M. avium subsp. paratuberculosis. We also tested milk artificially contaminated with Mycobacterium smegmatis as a candidate surrogate to compare thermal inactivation between M. smegmatis and M. avium subsp. paratuberculosis. Following the DSI process, no viable M. avium subsp. paratuberculosis or M. smegmatis was recovered using culture methods for both strains. For pure M. avium subsp. paratuberculosis cultures, a minimum reduction of 5.6 log10 was achieved with DSI, and a minimum reduction of 5.7 log10 was found with M. smegmatis. The minimum log10 reduction for wild-type M. avium subsp. paratuberculosis naturally present in feces was 3.3. In addition, 44 dairy and nondairy powdered infant formula (PIF) ingredients used during the manufacturing process of PIF were tested for an alternate source for M. avium subsp. paratuberculosis and were found to be negative by quantitative PCR (qPCR). In conclusion, the results obtained from this study indicate that a >7-fold-log10 reduction of M. avium subsp. paratuberculosis in milk can be achieved with the applied DSI process. IMPORTANCE: M. avium subsp. paratuberculosis is widespread in dairy herds in many countries. M. avium subsp. paratuberculosis is the causative agent of Johne's disease in cattle, and infected animals can directly or indirectly (i.e., fecal contamination) contaminate milk. Despite much research and debate, there is no conclusive evidence that M. avium subsp. paratuberculosis is a zoonotic bacterium, i.e., one that causes disease in humans. The presence of M. avium subsp. paratuberculosis or its DNA has been reported in dairy products, including pasteurized milk, cheese, and infant formula. In light of this, it is appropriate to evaluate existing mitigation measures to inactivate M. avium subsp. paratuberculosis in dairy products. The work conducted in this study describes the efficacy of direct steam injection, a thermal process commonly used in the dairy industry, to eliminate M. avium subsp. paratuberculosis and a surrogate bacterium in milk, thus ensuring the absence of M. avium subsp. paratuberculosis in dairy products subject to these process conditions.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26944840      PMCID: PMC4836428          DOI: 10.1128/AEM.04042-15

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  32 in total

1.  Quantitative real-time PCR and culture examination of Mycobacterium avium subsp. paratuberculosis at farm level.

Authors:  Shahram Hanifian; Sajjad Khani; Abolfazl Barzegari; Jalal Shayegh
Journal:  Vet Microbiol       Date:  2012-09-05       Impact factor: 3.293

2.  Effect of turbulent-flow pasteurization on survival of Mycobacterium avium subsp. paratuberculosis added to raw milk.

Authors:  L E Pearce; H T Truong; R A Crawford; G F Yates; S Cavaignac; G W de Lisle
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

3.  Fate of Mycobacterium avium subsp. paratuberculosis in Swiss hard and semihard cheese manufactured from raw milk.

Authors:  U Spahr; K Schafroth
Journal:  Appl Environ Microbiol       Date:  2001-09       Impact factor: 4.792

Review 4.  Heat inactivation data for Mycobacterium avium subsp. paratuberculosis: implications for interpretation.

Authors:  N Klijn; A A Herrewegh; P de Jong
Journal:  J Appl Microbiol       Date:  2001-10       Impact factor: 3.772

5.  Incidence of Mycobacterium paratuberculosis in bulk raw and commercially pasteurized cows' milk from approved dairy processing establishments in the United Kingdom.

Authors:  Irene R Grant; Hywel J Ball; Michael T Rowe
Journal:  Appl Environ Microbiol       Date:  2002-05       Impact factor: 4.792

6.  Mycobacterium avium subspecies paratuberculosis cultured from locally and commercially pasteurized cow's milk in the Czech Republic.

Authors:  Wuhib Y Ayele; Petra Svastova; Petr Roubal; Milan Bartos; Ivo Pavlik
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

7.  Effective heat inactivation of Mycobacterium avium subsp. paratuberculosis in raw milk contaminated with naturally infected feces.

Authors:  Jan L W Rademaker; Marc M M Vissers; Meike C Te Giffel
Journal:  Appl Environ Microbiol       Date:  2007-05-11       Impact factor: 4.792

8.  Evaluation of culture media for the recovery of Mycobacterium avium subsp. paratuberculosis from Cheddar cheese.

Authors:  J A Donaghy; N L Totton; M T Rowe
Journal:  Lett Appl Microbiol       Date:  2003       Impact factor: 2.858

9.  Comparison of milk culture, direct and nested polymerase chain reaction (PCR) with fecal culture based on samples from dairy herds infected with Mycobacterium avium subsp. paratuberculosis.

Authors:  Anli Gao; Joseph Odumeru; Melinda Raymond; Steven Hendrick; Todd Duffield; Lucy Mutharia
Journal:  Can J Vet Res       Date:  2009-01       Impact factor: 1.310

10.  Diagnosis of paratuberculosis in cattle: microbiological culture, serology and PCR.

Authors:  Isabel A Carvalho; Vinicius E B Campos; Iana M Souza; Larissa G Zanardo; Jose D Ribeiro Filho; Marcos J P Gomes; Maria A S Moreira
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

View more
  1 in total

1.  Genomic Detection of Mycobacterium avium subspecies paratuberculosis in Blood Samples of Patients with Inflammatory Bowel Disease in Southern Iran.

Authors:  Saeid Amirizadehfard; Mohammadreza Mahzounieh; Alireza Safarpour; Maryam Nejabat; Nazanin Nazari
Journal:  Iran J Med Sci       Date:  2020-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.